In vitro antimicrobial evaluation of Coated VICRYL Plus Antibacterial Suture (coated polyglactin 910 with triclosan) using zone of inhibition assays

In this study, coated polyglactin 910 suture with triclosan was evaluated for its ability to inhibit the growth of wild-type and methicillin-resistant Staphylococcus aureus and S. epidermidis using several in vitro models. In the standard experimental procedure, sterile sutures were inoculated with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surgical infections 2002, Vol.3 Suppl 1 (3, Supplement 1), p.S79-87
Hauptverfasser: Rothenburger, Stephen, Spangler, Daniel, Bhende, Shubhangi, Burkley, Daniel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 87
container_issue 3, Supplement 1
container_start_page S79
container_title Surgical infections
container_volume 3 Suppl 1
creator Rothenburger, Stephen
Spangler, Daniel
Bhende, Shubhangi
Burkley, Daniel
description In this study, coated polyglactin 910 suture with triclosan was evaluated for its ability to inhibit the growth of wild-type and methicillin-resistant Staphylococcus aureus and S. epidermidis using several in vitro models. In the standard experimental procedure, sterile sutures were inoculated with bacteria, plated in semisolid culture media, incubated for 24 h, and examined for zones of inhibition surrounding the sutures. Sutures were pretreated by several methods prior to inoculation, these included: 24-h aqueous immersion, serial 7-day aqueous immersion, knotting, and passage through subcutaneous and fascial tissue. Sutures were also compared to determine if suture diameter had an effect on the zone of inhibition. Coated polyglactin 910 suture with triclosan inhibited growth of test organisms consistently over a range of suture diameters and treatment conditions. The antibacterial effect was robust and did not diminish when sutures were placed in an aqueous environment for up to 7 days. Knotted suture with triclosan inhibited bacterial colonization after replicate inoculation. The bacteria-free zone surrounding each knotted suture had a volume of 14.5 cm(3) for S. epidermidis and 17.8 cm(3) for S. aureus. Coated polyglactin 910 suture with triclosan continued to produce zones of inhibition after five and 10 passes through fascia and subcutaneous tissue. These data support the conclusion that coated polyglactin 910 suture with triclosan provides antimicrobial effect sufficient to prevent in vitro colonization by S. aureus and S. epidermidis.
doi_str_mv 10.1089/10962960260496361
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72844470</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72844470</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1442-66afd928f6bc4ee0efb3c22fec6f345addf3daef09616bf79f9a92c0b15f8e913</originalsourceid><addsrcrecordid>eNplkMtKAzEUhrNQtF4ewI1kJbqoJpk00yyleCkUFG_gashkTmokTWqSqdTn8IGd2oILVwfO-f7_wIfQESXnlAzlBSVSMCkIE4RLUQi6hXqrXb9b8l20l9I7IbRkQuygXcoGZUE466HvsccLm2PAymc7szqG2iqHYaFcq7INHgeDR0FlaPDLePTwOsH3rk34ssNrpTPEFf7Y5jYCPtVrcB7ccuq6q_VYUoI_bX7DOVrtQlL-DLfJ-in-Ch5W7da_2dr-_lIpqWU6QNtGuQSHm7mPnq-vnka3_cndzXh0OelryjnrC6FMI9nQiFpzAAKmLjRjBrQwBR-opjFFo8B0FqioTSmNVJJpUtOBGYKkxT46WffOY_hoIeVqZpMG55SH0KaqZEPOeUk6kK7BTk9KEUw1j3am4rKipFrpr_7p7zLHm_K2nkHzl9i4L34AiS-FAA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72844470</pqid></control><display><type>article</type><title>In vitro antimicrobial evaluation of Coated VICRYL Plus Antibacterial Suture (coated polyglactin 910 with triclosan) using zone of inhibition assays</title><source>Mary Ann Liebert Journals</source><source>MEDLINE</source><creator>Rothenburger, Stephen ; Spangler, Daniel ; Bhende, Shubhangi ; Burkley, Daniel</creator><creatorcontrib>Rothenburger, Stephen ; Spangler, Daniel ; Bhende, Shubhangi ; Burkley, Daniel</creatorcontrib><description>In this study, coated polyglactin 910 suture with triclosan was evaluated for its ability to inhibit the growth of wild-type and methicillin-resistant Staphylococcus aureus and S. epidermidis using several in vitro models. In the standard experimental procedure, sterile sutures were inoculated with bacteria, plated in semisolid culture media, incubated for 24 h, and examined for zones of inhibition surrounding the sutures. Sutures were pretreated by several methods prior to inoculation, these included: 24-h aqueous immersion, serial 7-day aqueous immersion, knotting, and passage through subcutaneous and fascial tissue. Sutures were also compared to determine if suture diameter had an effect on the zone of inhibition. Coated polyglactin 910 suture with triclosan inhibited growth of test organisms consistently over a range of suture diameters and treatment conditions. The antibacterial effect was robust and did not diminish when sutures were placed in an aqueous environment for up to 7 days. Knotted suture with triclosan inhibited bacterial colonization after replicate inoculation. The bacteria-free zone surrounding each knotted suture had a volume of 14.5 cm(3) for S. epidermidis and 17.8 cm(3) for S. aureus. Coated polyglactin 910 suture with triclosan continued to produce zones of inhibition after five and 10 passes through fascia and subcutaneous tissue. These data support the conclusion that coated polyglactin 910 suture with triclosan provides antimicrobial effect sufficient to prevent in vitro colonization by S. aureus and S. epidermidis.</description><identifier>ISSN: 1096-2964</identifier><identifier>DOI: 10.1089/10962960260496361</identifier><identifier>PMID: 12573042</identifier><language>eng</language><publisher>United States</publisher><subject>Anti-Infective Agents, Local - administration &amp; dosage ; Anti-Infective Agents, Local - pharmacology ; Anti-Infective Agents, Local - therapeutic use ; Biological Assay ; Coated Materials, Biocompatible - pharmacology ; Coated Materials, Biocompatible - therapeutic use ; Colony Count, Microbial ; Contact Inhibition - drug effects ; Humans ; In Vitro Techniques ; Methicillin Resistance ; Polyglactin 910 - pharmacology ; Polyglactin 910 - therapeutic use ; Staphylococcal Infections - prevention &amp; control ; Staphylococcus aureus - drug effects ; Staphylococcus aureus - growth &amp; development ; Staphylococcus epidermidis - drug effects ; Staphylococcus epidermidis - growth &amp; development ; Time Factors ; Triclosan - administration &amp; dosage ; Triclosan - pharmacology ; Triclosan - therapeutic use</subject><ispartof>Surgical infections, 2002, Vol.3 Suppl 1 (3, Supplement 1), p.S79-87</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1442-66afd928f6bc4ee0efb3c22fec6f345addf3daef09616bf79f9a92c0b15f8e913</citedby><cites>FETCH-LOGICAL-c1442-66afd928f6bc4ee0efb3c22fec6f345addf3daef09616bf79f9a92c0b15f8e913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3029,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12573042$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rothenburger, Stephen</creatorcontrib><creatorcontrib>Spangler, Daniel</creatorcontrib><creatorcontrib>Bhende, Shubhangi</creatorcontrib><creatorcontrib>Burkley, Daniel</creatorcontrib><title>In vitro antimicrobial evaluation of Coated VICRYL Plus Antibacterial Suture (coated polyglactin 910 with triclosan) using zone of inhibition assays</title><title>Surgical infections</title><addtitle>Surg Infect (Larchmt)</addtitle><description>In this study, coated polyglactin 910 suture with triclosan was evaluated for its ability to inhibit the growth of wild-type and methicillin-resistant Staphylococcus aureus and S. epidermidis using several in vitro models. In the standard experimental procedure, sterile sutures were inoculated with bacteria, plated in semisolid culture media, incubated for 24 h, and examined for zones of inhibition surrounding the sutures. Sutures were pretreated by several methods prior to inoculation, these included: 24-h aqueous immersion, serial 7-day aqueous immersion, knotting, and passage through subcutaneous and fascial tissue. Sutures were also compared to determine if suture diameter had an effect on the zone of inhibition. Coated polyglactin 910 suture with triclosan inhibited growth of test organisms consistently over a range of suture diameters and treatment conditions. The antibacterial effect was robust and did not diminish when sutures were placed in an aqueous environment for up to 7 days. Knotted suture with triclosan inhibited bacterial colonization after replicate inoculation. The bacteria-free zone surrounding each knotted suture had a volume of 14.5 cm(3) for S. epidermidis and 17.8 cm(3) for S. aureus. Coated polyglactin 910 suture with triclosan continued to produce zones of inhibition after five and 10 passes through fascia and subcutaneous tissue. These data support the conclusion that coated polyglactin 910 suture with triclosan provides antimicrobial effect sufficient to prevent in vitro colonization by S. aureus and S. epidermidis.</description><subject>Anti-Infective Agents, Local - administration &amp; dosage</subject><subject>Anti-Infective Agents, Local - pharmacology</subject><subject>Anti-Infective Agents, Local - therapeutic use</subject><subject>Biological Assay</subject><subject>Coated Materials, Biocompatible - pharmacology</subject><subject>Coated Materials, Biocompatible - therapeutic use</subject><subject>Colony Count, Microbial</subject><subject>Contact Inhibition - drug effects</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Methicillin Resistance</subject><subject>Polyglactin 910 - pharmacology</subject><subject>Polyglactin 910 - therapeutic use</subject><subject>Staphylococcal Infections - prevention &amp; control</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus aureus - growth &amp; development</subject><subject>Staphylococcus epidermidis - drug effects</subject><subject>Staphylococcus epidermidis - growth &amp; development</subject><subject>Time Factors</subject><subject>Triclosan - administration &amp; dosage</subject><subject>Triclosan - pharmacology</subject><subject>Triclosan - therapeutic use</subject><issn>1096-2964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkMtKAzEUhrNQtF4ewI1kJbqoJpk00yyleCkUFG_gashkTmokTWqSqdTn8IGd2oILVwfO-f7_wIfQESXnlAzlBSVSMCkIE4RLUQi6hXqrXb9b8l20l9I7IbRkQuygXcoGZUE466HvsccLm2PAymc7szqG2iqHYaFcq7INHgeDR0FlaPDLePTwOsH3rk34ssNrpTPEFf7Y5jYCPtVrcB7ccuq6q_VYUoI_bX7DOVrtQlL-DLfJ-in-Ch5W7da_2dr-_lIpqWU6QNtGuQSHm7mPnq-vnka3_cndzXh0OelryjnrC6FMI9nQiFpzAAKmLjRjBrQwBR-opjFFo8B0FqioTSmNVJJpUtOBGYKkxT46WffOY_hoIeVqZpMG55SH0KaqZEPOeUk6kK7BTk9KEUw1j3am4rKipFrpr_7p7zLHm_K2nkHzl9i4L34AiS-FAA</recordid><startdate>2002</startdate><enddate>2002</enddate><creator>Rothenburger, Stephen</creator><creator>Spangler, Daniel</creator><creator>Bhende, Shubhangi</creator><creator>Burkley, Daniel</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2002</creationdate><title>In vitro antimicrobial evaluation of Coated VICRYL Plus Antibacterial Suture (coated polyglactin 910 with triclosan) using zone of inhibition assays</title><author>Rothenburger, Stephen ; Spangler, Daniel ; Bhende, Shubhangi ; Burkley, Daniel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1442-66afd928f6bc4ee0efb3c22fec6f345addf3daef09616bf79f9a92c0b15f8e913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Anti-Infective Agents, Local - administration &amp; dosage</topic><topic>Anti-Infective Agents, Local - pharmacology</topic><topic>Anti-Infective Agents, Local - therapeutic use</topic><topic>Biological Assay</topic><topic>Coated Materials, Biocompatible - pharmacology</topic><topic>Coated Materials, Biocompatible - therapeutic use</topic><topic>Colony Count, Microbial</topic><topic>Contact Inhibition - drug effects</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Methicillin Resistance</topic><topic>Polyglactin 910 - pharmacology</topic><topic>Polyglactin 910 - therapeutic use</topic><topic>Staphylococcal Infections - prevention &amp; control</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus aureus - growth &amp; development</topic><topic>Staphylococcus epidermidis - drug effects</topic><topic>Staphylococcus epidermidis - growth &amp; development</topic><topic>Time Factors</topic><topic>Triclosan - administration &amp; dosage</topic><topic>Triclosan - pharmacology</topic><topic>Triclosan - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rothenburger, Stephen</creatorcontrib><creatorcontrib>Spangler, Daniel</creatorcontrib><creatorcontrib>Bhende, Shubhangi</creatorcontrib><creatorcontrib>Burkley, Daniel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Surgical infections</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rothenburger, Stephen</au><au>Spangler, Daniel</au><au>Bhende, Shubhangi</au><au>Burkley, Daniel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro antimicrobial evaluation of Coated VICRYL Plus Antibacterial Suture (coated polyglactin 910 with triclosan) using zone of inhibition assays</atitle><jtitle>Surgical infections</jtitle><addtitle>Surg Infect (Larchmt)</addtitle><date>2002</date><risdate>2002</risdate><volume>3 Suppl 1</volume><issue>3, Supplement 1</issue><spage>S79</spage><epage>87</epage><pages>S79-87</pages><issn>1096-2964</issn><abstract>In this study, coated polyglactin 910 suture with triclosan was evaluated for its ability to inhibit the growth of wild-type and methicillin-resistant Staphylococcus aureus and S. epidermidis using several in vitro models. In the standard experimental procedure, sterile sutures were inoculated with bacteria, plated in semisolid culture media, incubated for 24 h, and examined for zones of inhibition surrounding the sutures. Sutures were pretreated by several methods prior to inoculation, these included: 24-h aqueous immersion, serial 7-day aqueous immersion, knotting, and passage through subcutaneous and fascial tissue. Sutures were also compared to determine if suture diameter had an effect on the zone of inhibition. Coated polyglactin 910 suture with triclosan inhibited growth of test organisms consistently over a range of suture diameters and treatment conditions. The antibacterial effect was robust and did not diminish when sutures were placed in an aqueous environment for up to 7 days. Knotted suture with triclosan inhibited bacterial colonization after replicate inoculation. The bacteria-free zone surrounding each knotted suture had a volume of 14.5 cm(3) for S. epidermidis and 17.8 cm(3) for S. aureus. Coated polyglactin 910 suture with triclosan continued to produce zones of inhibition after five and 10 passes through fascia and subcutaneous tissue. These data support the conclusion that coated polyglactin 910 suture with triclosan provides antimicrobial effect sufficient to prevent in vitro colonization by S. aureus and S. epidermidis.</abstract><cop>United States</cop><pmid>12573042</pmid><doi>10.1089/10962960260496361</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1096-2964
ispartof Surgical infections, 2002, Vol.3 Suppl 1 (3, Supplement 1), p.S79-87
issn 1096-2964
language eng
recordid cdi_proquest_miscellaneous_72844470
source Mary Ann Liebert Journals; MEDLINE
subjects Anti-Infective Agents, Local - administration & dosage
Anti-Infective Agents, Local - pharmacology
Anti-Infective Agents, Local - therapeutic use
Biological Assay
Coated Materials, Biocompatible - pharmacology
Coated Materials, Biocompatible - therapeutic use
Colony Count, Microbial
Contact Inhibition - drug effects
Humans
In Vitro Techniques
Methicillin Resistance
Polyglactin 910 - pharmacology
Polyglactin 910 - therapeutic use
Staphylococcal Infections - prevention & control
Staphylococcus aureus - drug effects
Staphylococcus aureus - growth & development
Staphylococcus epidermidis - drug effects
Staphylococcus epidermidis - growth & development
Time Factors
Triclosan - administration & dosage
Triclosan - pharmacology
Triclosan - therapeutic use
title In vitro antimicrobial evaluation of Coated VICRYL Plus Antibacterial Suture (coated polyglactin 910 with triclosan) using zone of inhibition assays
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T16%3A21%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20antimicrobial%20evaluation%20of%20Coated%20VICRYL%20Plus%20Antibacterial%20Suture%20(coated%20polyglactin%20910%20with%20triclosan)%20using%20zone%20of%20inhibition%20assays&rft.jtitle=Surgical%20infections&rft.au=Rothenburger,%20Stephen&rft.date=2002&rft.volume=3%20Suppl%201&rft.issue=3,%20Supplement%201&rft.spage=S79&rft.epage=87&rft.pages=S79-87&rft.issn=1096-2964&rft_id=info:doi/10.1089/10962960260496361&rft_dat=%3Cproquest_cross%3E72844470%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72844470&rft_id=info:pmid/12573042&rfr_iscdi=true